Wyse, PhD JJ, Morasco, PhD BJ, Dobscha, MD SK, Demidenko, BS MI, Meath, MPH THA, Lovejoy, PhD, MPH TI. Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified. J of Opioid Management [Internet]. 2018 Jul. 1 [cited 2024 Nov. 21];14(4):295-303. Available from: https://wmpllc.org/ojs/index.php/jom/article/view/1798